Skip to main content
HypertensionHeart and circulationDevice

What this study is

A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.

What's being tested

  • Medtronic Astra/Azure DR MRI IPG with AVIM therapy Activated

    Intervention · DEVICE

    Antihypertensive therapy utilizing atrioventricular interval modulation.

  • Medtronic Astra/Azure DR MRI IPG with AVIM therapy Deactivated

    Intervention · DEVICE

    AVIM therapy is deactivated

Study details

Sponsor
Orchestra BioMed, Inc
Conditions
Hypertension · Hypertension, Systolic · Hypertension, Essential
Enrolling
316 people
Starts
2023-12-27
Est. completion
2029-08
Design
Triple-blind, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗